EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Simultaneous quantification of Moxifloxacin and Linezolid in human plasma using a simple isocratic HPLC method: Application to pharmacokinetic studies in resource limited settings

Mustajab Ali Naseer, Muhammad Usman, Abdulhakeem S. Alamri, Majid Alhomrani, Walaa F. Alsanie, Muhammad Aamir

Acta Chromatographica · 11.06.2026

DOI: 10.1556/1326.2026.01503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Chromatographica, erschienen am 11.06.2026. Verfasst von Mustajab Ali Naseer und 5 weiteren Autor:innen. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Moxifloxacin and linezolid are key antibiotics used for multidrug-resistant tuberculosis (MDRTB) and other infections, including those caused by gram-positive bacteria like Mycobacterium tuberculosis and Methicillin-Resistant Staphylococcus Aureus (MRSA). Accurate and simultaneous quantification of these antibiotics in human plasma is essential for therapeutic drug monitoring and pharmacokinetic studies. The existing methods often focus on single drugs or require expensive Liquid Chromatography-Mass Spectrometry (LC-MS/MS) unavailable in resource limited settings like Pakistan.

Methods

An isocratic HPLC-UV method was developed using an Agilent 1100 system with a C18 column (250 × 4.6 mm), mobile phase of 0.1% formic acid:acetonitrile (75:25 v/v) at 1 mL min −1 , and detection at 292 nm (moxifloxacin) and 262 nm (linezolid). Sample preparation was done through protein precipitation with acetonitrile and liquid-liquid extraction. The method was validated following European Medicines Agency (EMA) guidelines for selectivity, linearity, within-run and between-run accuracy and precision, and stability at room temperature, freeze-thaw and long-term stability for 6 months.

Results

The method was selective for moxifloxacin and linezolid with no interfering peaks at retention times (4.4 min for moxifloxacin, 9 min for linezolid). The method was linear with r 2 ≥ 0.999 over the concentration range of moxifloxacin (0.2–12 mg L −1 ) and linezolid (0.5–30 mg L −1 ). The lower limit of quantification for moxifloxacin was 0.2 mg L −1 and for linezolid was 0.5 mg L −1 as determined by back calculation. The mean percentage relative recovery for accuracy was 91.6–111.8% for moxifloxacin and 88–97.9% for linezolid while RSD% for precision was ≤13.7% for moxifloxacin and ≤12.4% for linezolid. Both analytes remained stable at room temperature for 24 h, after four freeze and thaw cycles and also after storage at −20 °C for 6 months.

Conclusion

This validated, cost-effective HPLC-UV method enables reliable simultaneous quantification of moxifloxacin and linezolid in plasma, supporting pharmacokinetic research within resource constrained settings like Pakistan.

Zitieren

APA

Naseer, M. A., Usman, M., Alamri, A. S., Alhomrani, M., Alsanie, W. F., & Aamir, M. (2026). Simultaneous quantification of Moxifloxacin and Linezolid in human plasma using a simple isocratic HPLC method: Application to pharmacokinetic studies in resource limited settings. Acta Chromatographica. https://doi.org/10.1556/1326.2026.01503

Vancouver

Naseer MA, Usman M, Alamri AS, Alhomrani M, Alsanie WF, Aamir M. Simultaneous quantification of Moxifloxacin and Linezolid in human plasma using a simple isocratic HPLC method: Application to pharmacokinetic studies in resource limited settings. Acta Chromatographica. 2026. doi:10.1556/1326.2026.01503

BibTeX
@article{Naseer2026,
  author = {Naseer, Mustajab Ali and Usman, Muhammad and Alamri, Abdulhakeem S. and Alhomrani, Majid and Alsanie, Walaa F. and Aamir, Muhammad},
  title = {Simultaneous quantification of Moxifloxacin and Linezolid in human plasma using a simple isocratic HPLC method: Application to pharmacokinetic studies in resource limited settings},
  journal = {Acta Chromatographica},
  year = {2026},
  doi = {10.1556/1326.2026.01503}
}
Kostenlos starten →